Submit Release
News Search

There were 378 press releases posted in the last 24 hours and 437,922 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Pieris Pharmaceuticals Announces Dosing of First Patient in Phase I Combination Trial for PRS-343 Plus Anti-PD-L1 Immunotherapy

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.

We use cookies to enhance your experience. Learn more